🇺🇸 FDA
Pipeline program

KPT-330

KPT330-A1

Phase 1 small_molecule completed

Quick answer

KPT-330 for Solid Tumors is a Phase 1 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Karyopharm Therapeutics
Indication
Solid Tumors
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials